{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:40:17Z","timestamp":1759639217170,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"crossref","award":["CM24\/00019"],"award-info":[{"award-number":["CM24\/00019"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondo Europeo de Desarrollo Regional-FEDER"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Hypophosphatemia is a frequently underestimated metabolic disorder, yet it can be one of the first biochemical findings in primary hyperparathyroidism (PHPT). Current diagnostic and surgical criteria for PHPT do not include serum phosphate, despite its potential value as an early marker. Methods: We report the case of a 79-year-old woman with type 2 diabetes mellitus, hypertension and osteoarthritis, followed since 2015 for persistent hypophosphatemia (0.8 mg\/dL) and stress fractures. Results: Initial calcium and vitamin D levels were normal, but PTH was elevated. Bone scintigraphy revealed multiple stress fractures, while ultrasound and sestamibi scan were inconclusive. Despite cholecalciferol and calcitriol supplementation, hypophosphatemia persisted. From 2023, progressive hypercalcemia developed (10.9 mg\/dL), with sustained hypophosphatemia (1.7 mg\/dL), persistently high PTH (121 pg\/mL) and markedly elevated FGF-23 (1694 kRU\/L). Renal phosphate wasting was demonstrated, with reduced tubular reabsorption. An 18F-fluorocholine PET-CT performed in 2024 identified two right parathyroid adenomas, establishing the diagnosis of PHPT. The patient was referred for parathyroidectomy. Conclusions: Hypophosphatemia may serve as a complementary biomarker in the diagnostic and therapeutic approach to PHPT, but only after other potential causes of low phosphate levels have been excluded, as illustrated in this case. Its consideration could facilitate the early identification of PHPT and improve clinical decision-making, particularly in patients who do not meet classical surgical indications.<\/jats:p>","DOI":"10.3390\/jcm14197024","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:26:54Z","timestamp":1759505214000},"page":"7024","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypophosphatemia in the Diagnosis and Management of Primary Hyperparathyroidism"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-7626","authenticated-orcid":false,"given":"Rosario Paloma","family":"Cano-M\u00e1rmol","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Nutrition, Virgen de la Arrixaca University Clinical Hospital, 30120 Murcia, Spain"},{"name":"Pascual Parrilla Murcian Institute of Biosanitary Research (IMIB), 30120 Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-1012","authenticated-orcid":false,"given":"Inmaculada","family":"Ros-Madrid","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Virgen de la Arrixaca University Clinical Hospital, 30120 Murcia, Spain"},{"name":"Pascual Parrilla Murcian Institute of Biosanitary Research (IMIB), 30120 Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7452-4387","authenticated-orcid":false,"given":"Mar\u00eda Carmen","family":"Andreo-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, San Cecilio University Clinical Hospital, 18016 Granada, Spain"},{"name":"Granada Biosanitary Research Institute (Ibs. Granada), 18012 Granada, Spain"},{"name":"Biomedical Research Network Centre (CIBER), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-3260","authenticated-orcid":false,"given":"Manuel","family":"Mu\u00f1oz-Torres","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, San Cecilio University Clinical Hospital, 18016 Granada, Spain"},{"name":"Granada Biosanitary Research Institute (Ibs. Granada), 18012 Granada, Spain"},{"name":"Biomedical Research Network Centre (CIBER), 28029 Madrid, Spain"},{"name":"Department of Medicine, University of Granada, 18012 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: Summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J. Bone Min. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/CMED.S13147","article-title":"Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil","volume":"6","author":"Eufrazino","year":"2013","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101247","DOI":"10.1016\/j.beem.2018.09.013","article-title":"Primary hyperparathyroidism","volume":"38","author":"Silva","year":"2024","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: Review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ndt\/gfad188","article-title":"The basics of phosphate metabolism","volume":"39","author":"Wagner","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jbmr.4486","article-title":"An expert perspective on phosphate dysregulation with a focus on chronic hypophosphatemia","volume":"37","author":"Aljuraibah","year":"2022","journal-title":"J. Bone Min. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.eprac.2022.07.005","article-title":"Hypophosphatemia: A practical guide to evaluation and management","volume":"28","author":"Tebben","year":"2022","journal-title":"Endocr. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2213-8587(19)30426-7","article-title":"Approach to patients with hypophosphataemia","volume":"8","author":"Florenzano","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_10","first-page":"30","article-title":"Etiology of hypophosphatemia in adults","volume":"164","author":"Riancho","year":"2025","journal-title":"Med. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101851","DOI":"10.1016\/j.beem.2023.101851","article-title":"The pathophysiology of hypophosphatemia","volume":"38","author":"Ito","year":"2024","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1152\/physrev.00022.2017","article-title":"Phosphate as a signaling molecule and its sensing mechanism","volume":"98","author":"Michigami","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1507\/endocrj.EJ22-0239","article-title":"Advances in understanding of phosphate homeostasis and related disorders","volume":"69","author":"Michigami","year":"2022","journal-title":"Endocr. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/cs0560407","article-title":"Absorption of inorganic phosphate in the human small intestine","volume":"56","author":"Walton","year":"1979","journal-title":"Clin. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1681\/ASN.2014030317","article-title":"Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD","volume":"26","author":"Carreras","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Castellano, E., Attanasio, R., Boriano, A., Pellegrino, M., and Borretta, G. (2022). Serum phosphate: A neglected test in the clinical management of primary hyperparathyroidism. J. Clin. Endocrinol. Metab., 107.","DOI":"10.1210\/clinem\/dgab676"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101837","DOI":"10.1016\/j.beem.2023.101837","article-title":"Phosphate: An underrated component of primary hyperparathyroidism","volume":"38","author":"Bhadada","year":"2024","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/IJGM.S253246","article-title":"Evaluation of serum level of FGF23 and 1,25(OH)2D3 in primary hyperparathyroidism patients before and after parathyroidectomy","volume":"13","author":"Hassani","year":"2020","journal-title":"Int. J. Gen. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"116202","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer","year":"2022","journal-title":"Bone"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1007\/s00467-024-06395-5","article-title":"The role of fibroblast growth factor 23 in regulation of phosphate balance","volume":"39","author":"Wilson","year":"2024","journal-title":"Pediatr. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Min. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000527931","article-title":"Severe hypophosphatemia as the initial presentation of renal Fanconi\u2019s syndrome and distal renal tubular acidosis related to zoledronic acid: A case report and literature review","volume":"48","author":"Wu","year":"2023","journal-title":"Kidney Blood Press. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"bvac027","DOI":"10.1210\/jendso\/bvac027","article-title":"Parathyroid hormone regulates circulating levels of sclerostin and FGF23 in a primary hyperparathyroidism model","volume":"6","author":"Nagata","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.0.1510055","article-title":"Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism","volume":"151","author":"Yamashita","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12020-025-04173-3","article-title":"Phosphate metabolism in primary hyperpara-thyroidism: A real-life long-term study","volume":"88","author":"Columbu","year":"2025","journal-title":"Endocrine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/ejendo\/lvaf039","article-title":"Primary hyperparathyroidism induces erythropoietin resistance through fibroblast growth factor 23","volume":"192","author":"Huber","year":"2025","journal-title":"Eur. J. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ramanan, M., Tabah, A., Affleck, J., Edwards, F., White, K.C., Attokaran, A., and Laupland, K. (2024). Hypophosphataemia in critical illness: A narrative review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13237165"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI109244","article-title":"Hypophosphatemia and rhabdomyolysis","volume":"62","author":"Knochel","year":"1978","journal-title":"J. Clin. Invest."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11914-011-0081-0","article-title":"Rickets","volume":"9","author":"Mughal","year":"2011","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Mughal","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr. Connect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"154049","DOI":"10.1016\/j.metabol.2019.154049","article-title":"Management of X-linked hypophosphatemia in adults","volume":"103","author":"Lecoq","year":"2020","journal-title":"Metabolism"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"641543","DOI":"10.3389\/fendo.2021.641543","article-title":"Consensus recommendations for the diagnosis and management of X-linked hypophosphatemia in Belgium","volume":"12","author":"Laurent","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00198-020-05548-0","article-title":"Burden of disease associated with X-linked hypophosphataemia in adults: A systematic literature review","volume":"32","author":"Seefried","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00006123-200207000-00038","article-title":"Cervical spinal cord compression attributable to a calcified intervertebral disc in a patient with X-linked hypophosphatemic rickets: Case report and review of the literature","volume":"51","author":"Soehle","year":"2002","journal-title":"Neurosurgery"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40618-023-02064-w","article-title":"The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism","volume":"46","author":"Bostan","year":"2023","journal-title":"J. Endocrinol. Invest."},{"key":"ref_37","first-page":"20","article-title":"Isolated hypophosphataemia as an early marker of primary hyperparathyroidism","volume":"2021","author":"Alexander","year":"2021","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_38","first-page":"205","article-title":"Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia","volume":"67","author":"Varsavsky","year":"2020","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2215\/CJN.03720321","article-title":"Assessment of proximal tubular function by tubular maximum phosphate reabsorption capacity in heart failure","volume":"17","author":"Emmens","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/7024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:22:13Z","timestamp":1759638133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/7024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":39,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jcm14197024"],"URL":"https:\/\/doi.org\/10.3390\/jcm14197024","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,10,3]]}}}